MORRISTOWN, N.J., Oct. 16, 2019 /PRNewswire/ -- PLT Health
Solutions, Inc. announced today that it has begun offering
Zynamite® to the US market. Previously only available in
Europe and Asia, the ingredient has been the recipient of
four global awards for innovation. Zynamite is a patent-pending
proprietary Mangifera indica extract standardized to ≥ 60%
mangiferin, developed from sustainably harvested mango leaves. It
was developed as part of a comprehensive ethnobotanic screening
process designed to deliver a range of mental and physical
benefits. A self-GRAS ingredient, it has a portfolio of safety data
and has been the subject of 3 pre-clinical and 6 clinical studies.
The primary areas of application will be in cognitive health
products where it provides mental energy, and in active/sports
nutrition products where it has been demonstrated to improve both
peak power output and mean power output in fatigued and exhausted
subjects. The ingredient is manufactured by Nektium Pharma. S.L.
and marketed exclusively by PLT in the
United States, Mexico and
Canada.
According to Devin Stagg, Chief
Operating Officer at PLT Health Solutions, Zynamite is an exciting
addition to PLT Health Solutions Cognitive and Active/Sports
Nutrition ingredient portfolios because of the signature types of
clinically-studied benefits it can deliver to a broad range of
formulations. "Zynamite is a unique ingredient for which we see a
number of possibilities to help consumer products companies develop
truly differentiated formulations. In the cognitive space, we see
its ability to deliver non-stimulant mental energy, either by
itself or in combination with caffeine as a foundation for energy
products, study aids, cognitive performance products and more. In
the active/sports market, Zynamite brings a combination of mental
and physical benefits to pre-workout, post-workout and daily use
products," he said.
Enhanced Mental Energy in Cognitive Formulations
Zynamite is an ingredient that enhances mental energy.
Clinical studies of formulations containing Zynamite point to rapid
onset of enhanced brain electrical activity, with statistically
significant improvement in reaction time and calculation
performance.
PLT calls Zynamite a 'caffeine-similar' because it produces
brain wave activity similar to caffeine. Intriguingly, in
vivo studies of Zynamite have pointed to the potential for
synergies between Zynamite and low doses of caffeine, suggesting
that formulations that combine these ingredients will be attractive
to consumers. This sets up formulating options that include both
'stim' and 'non-stim' products.
Brain/Body Support for Active/Sports Nutrition
Zynamite supports both the mental and physical aspects of sports
performance. Four sports clinical studies of formulations
containing Zynamite® suggest that it improves both peak power
output and mean power output and can also reduce soreness and speed
recovery from heavy, intense workouts – all situations when
athletes need help the most.
In the sports studies conducted by Nektium, cycle ergometer
sprints were performed, during which peak and mean power output
were analyzed. In the fatigue study, peak power was increased by
12.5% using Zynamite. In subjects experiencing simulated
exhaustion, peak power was increased by 19.4%. Results were
statistically significant between active and placebo groups.
Faster reaction and quicker adaptation to changing conditions
are essential to high performance athletics. The cognitive benefits
of Zynamite combined with the physical make this ingredient a
unique solution and an exciting opportunity for consumer messaging
in consumer products.
According to Stagg, Zynamite has generated a great deal of
interest in the industry since in advance of its arrival in
North America. "Since its
introduction in 2018, Zynamite has won multiple awards including
Nutraingredients, Nutraingredients-Asia and Frost & Sullivan –
all of which recognized the cutting-edge possibilities for this
ingredient. We are looking forward to engaging consumer product
companies with this novel platform for enhancing performance in a
range of innovative products," he said.
For more information, visit www.PLTHealth.com.
Media
Contact:
|
Company
Contact:
|
Mark
Falconer
|
Steve
Fink
|
Sciencewerks
|
PLT Health Solutions,
Inc.
|
Voice:
407-412-9705
|
Voice: 973-984-0900
x214
|
E-mail:
226488@email4pr.com
|
E-mail:
226488@email4pr.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/plt-health-solutions-to-offer-zynamite-to-north-american-market-300939890.html
SOURCE PLT Health Solutions